Malaria Consortium   Report issue

Foundation Phase 4
Founded: London United Kingdom (2003)

Organization Overview

First Clinical Trial
2009
NCT00720811
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2016

Timeline

NOW
  • Now

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Glucosephosphate Dehydrogenase Deficiency (Phase 4)

Malaria (Phase 4)

Malaria, Falciparum (Phase 4)

Pneumonia (Phase 4)

Pregnancy Complications (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 4
  • # of Trial APIs: 9